Mumbai, 17, November 2026: In a case highlighting the importance of accurate diagnosis and specialised neurological care, a young male patient who had been struggling with severe spinal flexor spasms and difficulty walking for eight months underwent successful intrathecal baclofen pump implantation at Wockhardt Hospitals, Mumbai Central. The patient, whose condition had significantly affected his ability to work and perform everyday activities, had been experiencing considerable physical discomfort and a loss of independence.
The patient approached Dr Sheetal Goyal, Consultant Neurologist, Wockhardt Hospitals, Mumbai Central, after months of difficulty walking and persistent muscle spasms. Following a detailed clinical evaluation, Dr Goyal identified the underlying problem and recommended a baclofen trial to assess the patient's response to the medication.
Baclofen is a medication used to manage spasticity, a condition characterised by excessive muscle stiffness and involuntary muscle contractions. For patients with severe spasticity who may not respond adequately to conventional treatment, intrathecal baclofen therapy is a specialised treatment option. It involves delivering medication directly into the cerebrospinal fluid surrounding the spinal cord through an implanted pump, helping manage excessive muscle activity.
The response to the baclofen trial was particularly encouraging. Within just one hour, the patient demonstrated significant improvement and was able to walk. This response helped the medical team establish that he could benefit from long-term intrathecal baclofen therapy. Following this assessment, an intrathecal baclofen pump was successfully implanted.
Explaining the case, Dr Sheetal Goyal, Consultant Neurologist, Wockhardt Hospitals, Mumbai Central, said, "This patient had been struggling for nearly eight months, during which his mobility, professional life and confidence were significantly affected. When he came to us, it was important to identify the underlying cause rather than simply continue managing the symptoms. His response to the baclofen trial within an hour was remarkable and helped us determine that intrathecal baclofen therapy was an appropriate treatment option. Witnessing such improvement is deeply rewarding, as the ultimate goal is to help patients regain their independence and improve their quality of life."
Intrathecal baclofen therapy is used in carefully selected patients with severe spasticity. By delivering medication directly into the spinal fluid, the treatment can help reduce muscle stiffness and involuntary spasms, potentially improving mobility, comfort and independence.
The case underscores how accurate diagnosis, a carefully assessed treatment response and access to advanced neurological interventions can open new possibilities for patients living with debilitating movement-related difficulties.
